Daniel Vargas Pivato de Almeida

Medical Oncologist Hospital Sírio-Libanês Brasília-DF. Co-Chair GU @LACOG_group. News editor @MOCBrasil. Former fellow GU oncology @sloan_kettering.

[Daniel Vargas Pivato de Almeida @drdanielvargas]

Thrilled to be part of this incredible team!

The LACOG GU group has evolved significantly in recent years as a natural result of the important achievements made by our investigators and administrative staff.

[LACOG - Latin American Cooperative Oncology Group @LACOG_group]

We are pleased to announce the Brazil and LATAM Board members of the LACOG Genitourinary Group.
This new board term will run from 2025 to 2027, with a continued focus on the development of innovative clinical and epidemiological studies.

#LACOG
#CancerResearch

[Daniel Vargas Pivato de Almeida @drdanielvargas]

@SylvesterCancer @DrTracyECrane Very well deserved! It's fantastic how your research impacts not only your patients, but also inspires researchers worldwide!

[MOC Brasil @MOCBrasil]

Regime combinado perioperatório é aprovado pelo FDA para câncer de bexiga músculo-invasivo

Fase 3 KN905/EV-303: enfortumabe + pembrolizumabe perioperatório aumentou SLE e SG no MIBC inelegível ou com recusa à QT cisplatina

@drdanielvargas @FabioSchutz78
https://t.co/MqwGPpyuNB

[Petros Grivas @PGrivasMDPhD]

Excellent talk by @Ric_Campi on adjuvant RCC setting with thoughtful comments on multi-D strategy & shared decision making! @OncoAlert @mirrorsmed @b_szabados @Uromigos @mtsiatas @MichalisLiontos @spsutkaMD @EvanHallMD @drdanielvargas @cdanicas @PavlosMsaouel @LauraBukavinaMD

[FLoscoMD @fedelosco]

GU Review 2025 | 27–29 nov | São Paulo + online.
Actualización clave en tumores genitourinarios con referentes internacionales.
Acceso libre a la transmision virtual
https://t.co/5oXBHvFJnk
@LACOG_group @aaoncoclinica @ASCO @Marco_Care_AI @UroTarget @Blatam_urology

[Daniel Vargas Pivato de Almeida @drdanielvargas]

Sharing this excellent initiative led by my friends @fedelosco @mflazzaro_gu and others!

Sad for not being able to join in person!

[FLoscoMD @fedelosco]

🎯 #UroTarget cumple 10 años. Lo que nació como una reunión es hoy una comunidad y una forma de cuidar.
Gracias @mflazzaro_gu 💙 #Oncología #UroOncología
@aaoncoclinica @ASCO @Blatam_urology

[Daniel Vargas Pivato de Almeida @drdanielvargas]

@VivekSubbiah @PGrivasMDPhD @fredhutch @HutchPresident @mshadman @VenurVyshak Congrats! Well deserved @PGrivasMDPhD !!!

[MOC Brasil @MOCBrasil]

ESMO 2025: Câncer de próstata | Dr. Daniel Vargas

Assista os destaques da #ESMO25 na área de Câncer de próstata, com apresentação do Dr. Daniel Vargas
e participação do Dr. Fabio Schutz

#MOCnaESMO #prostatecancer @drdanielvargas @FabioSchutz78
https://t.co/gBWscbHBan

[MOC Brasil @MOCBrasil]

ESMO 2025: Câncer de Rim e Bexiga | Dr Daniel Vargas

Nesta aula, Dr Daniel Vargas apresenta os destaques de Câncer de Rim e Bexiga da #ESMO25, com posterior discussão clínica com Dr Fabio Schutz. Não perca!

#MOCnaESMO @drdanielvargas @FabioSchutz78
https://t.co/fCet0ielMu

[Fernando Sabino, MD, PhD @fsabino_onco]

‼️Just Out at @JAMAOnc our Ph2 trial showing the efficacy of ICI with Chemotherapy in advanced PSCC.
Pembrolizumab Plus Platinum Chemotherapy in Advanced Penile Cancer https://t.co/cCEDoqHs6k

[Daniel Vargas Pivato de Almeida @drdanielvargas]

@zapatalaguadomd @OncoAlert @oncodaily @achoHematoYOnco @SCUColombia @urotoday @UroTarget You are fantastic, my friend!
🚀🚀🚀
Those difficult decisions are part of the hard work!
Congrats!

[Daniel Vargas Pivato de Almeida @drdanielvargas]

@PGrivasMDPhD @FabioSchutz78 @DrAndreFay @bavilima @ArielKann @PauloBergerot @crisbergerot Thank you for the kind words, @PGrivasMDPhD. Looking forward to more connections and future contributions in other projects.

[Paulo G Bergerot @PauloBergerot]

Thank you @PGrivasMDPhD for spending such a fantastic time with our group in #Brasília!
We’re deeply honored to have you with us at this unforgettable dinner. #BladderCancer
@drdanielvargas @oncoclinicas (and @crisbergerot photobombing in the corner😂)

[MOC Brasil @MOCBrasil]

ASCO 2025: Câncer de próstata | Dr Daniel Vargas

Fique por dentro dos highlights da #ASCO25 em Câncer de próstata, com apresentação dos destaques pelo Dr Daniel Vargas e moderação do Dr Fernando Maluf

#MOCnaASCO @drdanielvargas @FabioSchutz78
https://t.co/juM0aHAsta

[Daniel Vargas Pivato de Almeida @drdanielvargas]

During the last #ASCO25 session on Prostate Cancer, presentation of updated data on #IronMan trial w/ our Brazilian PI @DrAndreFay. Last day only for the brave ones!

@LACOG_group @IRONMANregistry

[Daniel Vargas Pivato de Almeida @drdanielvargas]

Once again meeting the @LACOG_group board members and affiliates during the @ASCO meeting. We ahead the opportunity to renew our brand mark and resilience to develop research projects in the region!

[Daniel Vargas Pivato de Almeida @drdanielvargas]

Excellent first day at #ASCO25 , starting with another productive session w/ the incentive of ICRC Scholars Program of @ASCO for LatAm

[Daniel Vargas Pivato de Almeida @drdanielvargas]

@PauloBergerot

[Daniel Vargas Pivato de Almeida @drdanielvargas]

Fantastic work by @PauloBergerot exploring this very important topic in LatAm.

[Paulo G Bergerot @PauloBergerot]

Our study reveals stark disparities in exercise referrals in LATAM

Oncologists in public 🏥 are less likely to assess, refer or guide pts on exercise due to limited resources&training

See you there! #ASCO25
@crisbergerot @fitaftercancer @GlopesMd @EnriqueSoto8 @NarjustFlorezMD

[Paulo G Bergerot @PauloBergerot]

Our study reveals stark disparities in exercise referrals in LATAM

Oncologists in public 🏥 are less likely to assess, refer or guide pts on exercise due to limited resources&training

See you there! #ASCO25
@crisbergerot @fitaftercancer @GlopesMd @EnriqueSoto8 @NarjustFlorezMD